In trading on Tuesday, shares of Incyte Corporation (Symbol: INCY) entered into oversold territory, hitting an RSI reading of 27.5, after changing hands as low as $58.16 per share. By comparison ...

Even though the stock has become cheaper, we don't have much confidence in Incyte. Here are three reasons why there are better opportunities than INCY and a stock we'd rather own. Founded in 1991 and ...

However, on March 17, Wolfe Research maintained a Buy rating on Incyte (NASDAQ: INCY). Based on Incyte’s latest earnings release for the quarter ending December 31, the company reported a ...

Lopez’s recent credits include the 2024 movies Atlas and Unstoppable. Deadline was first to report on the negotiations for Kiss of the Spider Woman.

Today, LOLtron brings you a preview of Spectacular Spider-Men #14, swinging into comic shops this Wednesday. How can the SPIDER-MEN hope to foil the ELECTROS' sinister plan when they're at the ...

In terms of Spider-Man missing from Doomsday, it's unclear whether Marvel Studios is saving his announcement for a later date. Thankfully, it's not like Holland will be gone from the MCU for long ...

This is the Top Ten Bleeding Cool Bestseller List, as compiled by over a hundred direct market comic stores from their sales from Wednesday to Friday, the "Wednesday Warriors". The chart is ...

WAtoday revealed last year that the only known habitat of the peacock jumping spider species Maratus yanchep was just 20 metres from Peet’s Elavale estate, putting it at high risk of extinction.

Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron (NASDAQ:REGN) and its peers. Over the next few years, immuno ...